Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-015541
Filing Date
2025-02-06
Accepted
2025-02-06 17:21:51
Documents
1
Period of Report
2025-01-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3167
  Complete submission text file 0000950170-25-015541.txt   4852
Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
STAAB THOMAS R II (Reporting) CIK: 0001230708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39473 | Film No.: 25598470

Mailing Address 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826
Business Address 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826 888-536-7271
LENSAR, Inc. (Issuer) CIK: 0001320350 (see all company filings)

EIN.: 320125724 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)